Qiao R - Search Results

1

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer.

Rogic A, Pant I, Grumolato L, Fernandez-Rodriguez R, Edwards A, Das S, Sun A, Yao S, Qiao R, Jaffer S, Sachidanandam R, Akturk G, Karlic R, Skobe M, Aaronson SA. Rogic A, et al. Among authors: qiao r. Nat Commun. 2021 Nov 25;12(1):6889. doi: 10.1038/s41467-021-27108-8. Nat Commun. 2021. PMID: 34824220 Free PMC article.

2

ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.

Esposito D, Pant I, Shen Y, Qiao RF, Yang X, Bai Y, Jin J, Poulikakos PI, Aaronson SA. Esposito D, et al. Nat Commun. 2022 Feb 4;13(1):703. doi: 10.1038/s41467-022-28319-3. Nat Commun. 2022. PMID: 35121738 Free PMC article.

3

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

Dong J, Phelps RG, Qiao R, Yao S, Benard O, Ronai Z, Aaronson SA. Dong J, et al. Among authors: qiao r. Cancer Res. 2003 Jul 15;63(14):3883-5. Cancer Res. 2003. PMID: 12873977

4

N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma.

Nagi C, Guttman M, Jaffer S, Qiao R, Keren R, Triana A, Li M, Godbold J, Bleiweiss IJ, Hazan RB. Nagi C, et al. Among authors: qiao r. Breast Cancer Res Treat. 2005 Dec;94(3):225-35. doi: 10.1007/s10549-005-7727-5. Breast Cancer Res Treat. 2005. PMID: 16258702

5

USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation.

Mungamuri SK, Qiao RF, Yao S, Manfredi JJ, Gu W, Aaronson SA. Mungamuri SK, et al. Cell Rep. 2016 Mar 22;14(11):2528-37. doi: 10.1016/j.celrep.2016.02.049. Epub 2016 Mar 10. Cell Rep. 2016. PMID: 26971997 Free PMC article.

6

Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.

Narla G, DiFeo A, Yao S, Banno A, Hod E, Reeves HL, Qiao RF, Camacho-Vanegas O, Levine A, Kirschenbaum A, Chan AM, Friedman SL, Martignetti JA. Narla G, et al. Cancer Res. 2005 Jul 1;65(13):5761-8. doi: 10.1158/0008-5472.CAN-05-0217. Cancer Res. 2005. PMID: 15994951

7

Evidence against a role for SV40 in human mesothelioma.

Manfredi JJ, Dong J, Liu WJ, Resnick-Silverman L, Qiao R, Chahinian P, Saric M, Gibbs AR, Phillips JI, Murray J, Axten CW, Nolan RP, Aaronson SA. Manfredi JJ, et al. Among authors: qiao r. Cancer Res. 2005 Apr 1;65(7):2602-9. doi: 10.1158/0008-5472.CAN-04-2461. Cancer Res. 2005. PMID: 15805256

8

Loss of p16INK4A expression in low-grade ovarian serous carcinomas.

Schlosshauer PW, Deligdisch L, Penault-Llorca F, Fatemi D, Qiao R, Yao S, Pearl M, Yang Z, Sheng T, Dong J. Schlosshauer PW, et al. Among authors: qiao r. Int J Gynecol Pathol. 2011 Jan;30(1):22-9. doi: 10.1097/PGP.0b013e3181ed89b3. Int J Gynecol Pathol. 2011. PMID: 21131838

9

A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics.

Xin L, Qiao R, Chen X, Tran H, Pan S, Rabinoviz S, Bian H, He X, Morse B, Shan B, Li M. Xin L, et al. Among authors: qiao r. Nat Commun. 2022 Jun 7;13(1):3108. doi: 10.1038/s41467-022-30867-7. Nat Commun. 2022. PMID: 35672356 Free PMC article.

10

Cadherin switch in tumor progression.

Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Hazan RB, et al. Among authors: qiao r. Ann N Y Acad Sci. 2004 Apr;1014:155-63. doi: 10.1196/annals.1294.016. Ann N Y Acad Sci. 2004. PMID: 15153430 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters